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Abstract Facial appearance is largely determined by the
morphology of the underlying skeleton. Hydroxyapatite is
one of several materials available to enhance projection of
the facial skeleton. This study evaluated the long-term
maintenance of augmented bony projection when porous
hydroxyapatite granules are used on the facial skeleton.
Ten female patients aged 28–58 years were studied fol-
lowing aesthetic augmentation of the facial skeleton at 24
sites using porous hydroxyapatite granules. Postoperative
CT scans at 3 months served as the baseline measurement
and compared with scans taken at 1 and 2 years, with the
thickness of the hydroxyapatite measured in axial and
coronal planes. Thickness of original bone plus overlay of
hydroxyapatite, thickness of the overlying soft tissue, and
the overall projection (bone plus soft tissue) were recorded.
It was found that 99.7% of the hydroxyapatite was main-
tained at 2 years, with no statistical difference (t test) from
the baseline measurement. The overall projection (bony
and soft tissue) was maintained as there was no evidence of
native bone resorption or soft tissue atrophy. Radiographic
results conﬁrmed that the use of porous hydroxyapatite
granules for enhancement of the facial skeleton is not only
a predictable procedure, but maintains full bony projection
at 2 years.
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Facial appearance is largely determined by the morphology
and relative prominence of areas of the underlying skele-
ton. With aging, areas of the facial skeleton undergo
resorption contributing to laxity and descent of the soft
tissue. Prominent ‘‘cheekbones’’ are considered youthful
and prolong a younger appearance with aging [1–4] and a
well-deﬁned mandibular rim is fundamental to having a
good and lasting neckline. Accordingly, surgical augmen-
tation of the skeleton signiﬁcantly enhances a person’s
facial appearance and provides a more youthful look.
Augmentation of the facial skeleton has progressed since
the early use of onlay silicone implants to treat malar
asymmetries in the early 1960s [3]. The techniques devel-
oped initially for reconstructive surgery were employed for
aesthetic indications in the early 1970s and included the use
of both autogenous and alloplastic materials.
Autogenous bone grafts have been regarded as the pre-
ferred material for facial reconstruction. However, the dis-
advantages of donor site morbidity, limited moldability, and
unpredictable postoperative resorption have limited their
appeal for the aesthetic patient [5–8]. Accordingly, alloplas-
tic implants derived from polymers and ceramics, usually in
preformed shapes, have been favored in facial augmentation
for aesthetic purposes [5, 8–14]. Preformed silicone and
porouspolyethylene(Medpor,PorexCorporation,Newman,
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DOI 10.1007/s00266-010-9473-2GA) are currently the most used allografts. The recognized
risks with these are minimal but include malposition,
infection,thinningoftheoverlyingsofttissues,andexposure
[15, 16].
Hydroxyapatite is a biocompatible alloplast and a pro-
ven alternative for augmentation of the facial skeleton,
having been used and studied for over two decades [10, 17–
19]. Hydroxyapatite, a calcium phosphate compound
[Ca10(PO4)6(OH)2], is the major mineral component of
bone [9, 20–23] (Fig. 1). The porous, coral-derived type
(Interpore 200, Interpore Orthopaedics, Inc., Irvine, CA) is
formed by a hydrothermal exchange reaction of marine
coral through the conversion of calcium carbonate coral to
hydroxyapatite, which maintains the natural porous
superstructure [17, 18]. Porous hydroxyapatite for aug-
mentation is available in both granule and block form. The
granular variant is associated with more predictable results
and fewer complications [24]. In addition, the granular
form requires considerably less operative exposure and soft
tissue dissection.
A challenge associated with onlay implants is the pre-
vention of postoperative movement and migration. An
advantage of using hydroxyapatite is the inherent biologi-
cal ﬁxation, which means the graft is not prone to displace,
extrude, or resorb which subsequently improves long-term
results [5]. Previous studies have shown that the porous
form (200 nm diameter) enables ﬁbrovascular and, in some
procedures, bony in-growth [25–27]. Hydroxyapatite is an
alternative to bone grafts in orthognathic surgery and cra-
niofacial reconstruction [28–32] and, in these applications,
becomes subsequently incorporated into natural bone.
Since the porous form of hydroxyapatite has been postu-
lated to grow into bone in speciﬁc surgical procedures,
although it is not osteoinductive [9, 19, 23, 27], it resists
infection by creating a vascularized framework through the
granules [16, 33–35]. Since it is biocompatible because it
has the same mineral composition as bone, hydroxyapatite
is also readily incorporated within the subperiosteal layer
without inducing a foreign-body reaction [17, 36–38]. The
advantage of being highly malleable also allows intraop-
erative shaping for the desired result.
Hydroxyapatite is not used as widely as would be
expected for augmentation of facial shape given its proven
qualities of safety, versatility, and long-term use. A possible
reason for this lack of popularity may be the absence of
conclusive data regarding the long-term maintenance of the
augmentedvolume.Toevaluatethelong-termfateofporous
hydroxyapatite granules used in augmentation of the facial
skeleton, a prospective radiologic study was performed over
a 2-year follow-up period using thin-slice CT scans.
Materials and Methods
Over a 1-year period (2004–2005), 24 patients underwent
augmentation of the facial skeleton for aesthetic enhance-
ment using porous hydroxyapatite granules (Pro Osteon
200, Interpore Cross International, Irvine, CA). The pro-
cedures were performed by the senior surgeon (BCM). Ten
patients agreed to be part of this prospective study. All were
females between 28 and 58 years (mean = 42.9 years).
Eight patients underwent additional procedures at the
time of the facial skeletal augmentation, including blepha-
roplasty (6), facelift (5), browlift (1), rhinoplasty (1), and
lipoinﬁltration (2).
Preoperative planning for the location and quantity of
hydroxyapatite to be used was determined by a trial volume
injection using local anesthetic. The procedures were per-
formed under general anesthesia with systemic antibiotic
coverage(Cephalothin1 g ? Gentamicin0.08 g).Aprecise
subperiosteal pocket was made in the planned area of aug-
mentation. A standard mixture of hydroxyapatite granules,
ﬁbrillar collagen (Spongostan Powder, Johnson & Johnson,
Skipton, UK), and the patient’s blood was prepared
according to the technique recommended by Byrd [24]. An
additional 20% was placed to allow for postoperative com-
paction associated with resolution of the degradable content
of the injected mixture. The subperiosteal hydroxyapatite
was then molded to obtain the desired contour. Several
patients had augmentation at multiple sites.
With consent, ten patients completed three postoperative
CT scans at 3 months, 1 year, and 2 years. All were per-
formed by the same radiologist (ALM) using a GE Light-
speed 16 Multidetector-Row CT scanner (GE Healthcare,
Milwaukee, WI). The patients were scanned supine with
multislice acquisitions obtained in the axial plane through
the relevant section of the face. The images were then
reconstructed at 0.625 mm collimation with isotropic
reconstructions—equivalent thickness to original axial
Fig. 1 Scanning electron micrographs of Pro Osteon 200 hydroxy-
apatite as used in augmentation of the facial skeleton (left) and the
similar physical structure of human cancellous bone (right) (images
courtesy of Interpore Cross International: reproduced with permission)
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123acquisitions in coronal, sagittal, and parasaggital planes
(Fig. 2). Three-dimensional facial contour, bone contour,
and volume-rendered reformatted images (Fig. 3) were
completed on the GE AWA workstation. Measurements
were taken in two planes (axial and coronal) where
hydroxyapatite had been placed. Thickness of bone (ori-
ginal bone plus overlay of hydroxyapatite), thickness of the
overlying soft tissue, and the overall projection (bone plus
soft tissue) was recorded in millimeters. Linear measure-
ments were more feasible than volumetric calculations and
would similarly demonstrate the in situ behavior of the
hydroxyapatite granules. The 3-month CT measurements
served as the baseline and these results were compared
with measurements obtained from the precise correspond-
ing images on the 1- and 2-year CT scans.
The measurements acquired from the 1- and 2-year
scans were each divided by the baseline measurement from
the 3-month scan yielding a percentage of the baseline
distance, i.e., 1-year measurement in mm/3-month mea-
surement in mm and 2-year measurement in mm/3-month
measurement in mm (Fig. 4). Statistical analysis was per-
formed on the overall projection, bony thickness, and soft
tissue thickness.
The patients’ clinical charts were reviewed for age,
location of augmentation, volume of hydroxyapatite used at
each site, simultaneous procedures performed, complica-
tions, infection, local reaction, revision procedures, and the
duration of clinical follow-up.
Results
The areas of skeletal augmentation included the prejowl
region over the mandible (10), zygomaticomaxillary (10),
and pyriform (4) regions. The average volume of
hydroxyapatite granule mixture placed at each site was
1.6 ml (range = 0.4–3.5 ml). The radiological evaluation
showed that 99.7% of the hydroxyapatite augmentation
was maintained at 2 years when compared to the 3-month
baseline measurements. The t test showed no statistical
Fig. 2 Axial (left) and coronal
(right) CT images showing
hydroxyapatite overlying the
body of the zygoma (shaded
yellow on patient’s right)
Fig. 3 3-D reconstructed CT
images of the facial skeleton
demonstrating the contour and
thickness of hydroxyapatite
placed over the zygomatic body
(left) and prejowl region of
mandibular body (right)
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123difference. There was no radiographic evidence of soft
tissue atrophy or native bone resorption on the 1- and
2-year scans. Overall projection (bony and soft tissue) was
maintained at the 2-year follow-up.
Sequelae were limited to minor bruising, swelling, and
moderate discomfort requiring a limited course of analge-
sia. No infections occurred during the 28 months of mean
follow-up. One patient required a small revision procedure
for aesthetic reasons. A small bulge of incorrectly placed
granules over the mandibular rim was corrected by removal
of localized excess granules and the associated ﬁbrous
tissue through the original incision.
Discussion
Underlying every attractive face is a skeleton that is pro-
portional and well balanced. The unique form of the pro-
jection of the face determines the extent of a person’s
attractiveness [39]. The aesthetic outcome is ultimately
determined by the facial soft tissue being well supported by
a skeletal foundation [4]. Facial balance can be corrected or
enhanced through augmentation of the zygomatic promi-
nence, maxilla, mandible, nose, and supraorbital ridges
[40] to achieve aesthetically pleasing proportions.
Beginning with Snyder’s description of dermal grafts for
treating malar facial agenesis in 1956 [41], many tech-
niques and materials have since been used for augmenta-
tion of the facial skeleton. Osteotomies were introduced to
enhance the morphology of the face [42], and subperiosteal
autogenous bone grafts were utilized for unilateral cor-
rective malarplasty [43, 44]. Alloplastic implants were
soon developed in parallel to these techniques, with Hin-
derer using silicone [45] and Spadafora et al. using
polyethylene [46] for malar augmentation. Other alloplastic
materials used have included ivory, metal, acrylic resins,
and ceramics [16, 47]. Regardless of implant choice, all
implanted materials should possess the basic attributes of
being chemically inert, nontoxic, and incapable of inducing
hypersensitivity or a foreign body reaction.
Combining hydroxyapatite granules with the patient’s
blood and additional collagen (Spongostan Powder) pro-
duces a material that provides the ﬂexibility of tailoring the
shape to the area of correction [24, 25, 27]. The mixture
has a hemostatic effect and apparent resistance to infection
[33]. There is little tendency for granule migration when
the hydroxyapatite mixture is placed in a precise subperi-
osteal pocket [24, 25, 27]. Although the surgeon is required
to custom-make the implant instead of using ‘‘off-the-
shelf’’ alternatives, the need for speciﬁc ﬁxation of the
Fig. 4 Axial (top) and
corresponding coronal (bottom)
CT images of the mandibular
body showing the thickness of
the hydroxyapatite maintained
over a 2-year period (shaded
yellow on patient’s right)
Fig. 5 Intraoperative view immediately following placement of
hydroxyapatite on the right maxilla and zygoma (2.8 ml granule
mixture) with subperiosteal midcheek lift. Left side dissected but not
yet augmented or lifted
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123implant, such as screws needed for porous polyethylene
implants, is avoided. This is because of the biological
integration of hydroxyapatite. Given the advantages of
limited dissection, minimal morbidity, and minimal risk of
complications, skeletal augmentation using hydroxyapatite
widens the indications for its use so that patients who could
beneﬁt from a small-volume augmentation and are not
candidates for traditional solid implants can reasonably
beneﬁt.
Compaction of the hydroxyapatite granules occurs dur-
ing the ﬁrst few weeks postsurgery and is completely stable
by 6 months [48], with the postoperative reduction in
projection averaging less than 10% [49, 50]. This is why
baseline scans were obtained at 3 months to accommodate
the anticipated settling and dimensional change.
Although this CT study had only a 2-year follow-up, the
fact that the augmented volume is completely maintained
suggests the result could be permanent. This is conﬁrmed
by other longer-term studies that report that hydroxyapatite
maintains a permanent contour over 4 years, although
those studies were clinical and less objective [6, 51, 52].
Augmentation of the facial skeleton is expected to
become increasingly important as the expectations for
aesthetic surgery results become more sophisticated. Now
that there is no longer the uncertainty about the mainte-
nance of the beneﬁt when hydroxyapatite is used, it is
reassuring that this approach to facial glamorization and
rejuvenation is soundly based (Figs. 5, 6).
Conclusion
This study provides clear radiographic evidence that por-
ous hydroxyapatite granules maintain bony and overall
projection at 2 years when used for augmentation of the
facial skeleton in the aesthetic patient. The completeness of
the volume maintenance, although only over a 2-year fol-
low-up in our study, suggests that the volume enhancement
may be permanent.
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